Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population

被引:150
|
作者
Kamino, K
Nagasaka, K
Imagawa, M
Yamamoto, H
Yoneda, H
Ueki, A
Kitamura, S
Namekata, K
Miki, T
Ohta, S
机构
[1] Nippon Med Sch, Inst Gerontol, Dept Biochem & Cell Biol, Nakahara Ku, Kawasaki, Kanagawa 2118533, Japan
[2] Hyogo Prefectural Amagasaki Hosp, Dept Psychiat, Amagasaki, Hyogo 6600828, Japan
[3] Osaka Municipal Kohsaiin Hosp, Dept Internal Med, Osaka 5650874, Japan
[4] Osaka Med Coll, Dept Neuropsychiat, Osaka 5698686, Japan
[5] Jichi Med Sch, Omiya Med Ctr, Dept Neurol, Omiya, Saitama 3308503, Japan
[6] Nippon Med Sch, Dept Internal Med 2, Bunkyo Ku, Tokyo 1138603, Japan
[7] Univ Tokyo, Fac Med, Grad Sch, Dept Neuropathol,Bunkyo Ku, Tokyo 1130033, Japan
[8] Ehime Univ, Sch Med, Dept Geriatr Med, Matsuyama, Ehime 7910295, Japan
关键词
Alzheimer's; mitochondria; acetoaldehyde; genetics; apolipoprotein E;
D O I
10.1006/bbrc.2000.2923
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitochondrial aldehyde dehydrogenase 2 (ALDH2) deficiency is caused by a mutant allele in the Mongoloids, To examine whether genetic constitutions affecting aldehyde metabolism influence the risk for late-onset Alzheimer's disease (LOAD), we performed a case-control study in the Japanese population on the deficiency in ALDH2 caused by the dominant-negative mutant allele of the ALDH2 gene (ALDH2*2), In a comparison of 447 patients with sex, age, and region matched nondemented controls, the genotype frequency carrying the ALDH2*2 allele was significantly higher in the patients than in the controls (48.1% vs 37.4%, P = 0.001), Logistic regression analysis indicates that carriage of the ALDH2*2 allele is an independent risk for LOAD of the epsilon 4 allele of the apolipoprotein E gene (APOE-epsilon 4) (P = 0.002). Moreover, the odds ratio for LOAD in carriers of the ALDH2*2 allele was almost twice that in noncarriers, irrespective of status with regard to the APOE-epsilon 4 allele, Among patients homozygous for the APOE-epsilon 4 allele, age at onset of LOAD was significantly lower in those with than without the ALDH2*2 allele, In addition, dosage of the ALDH2*2 allele significantly affected age at onset of patients homozygous for the APOE-epsilon 4 allele, These results indicate that the ALDH2 deficiency is a risk for LOAD. synergistically acting with the APOE-epsilon 4 allele. (C) 2000 Academic Press.
引用
收藏
页码:192 / 196
页数:5
相关论文
共 50 条
  • [31] Investigation of MAPT Subhaplotypes as Risk Factors for Late-Onset Alzheimer's Disease
    Allen, Mariet
    Kachadoorian, Michaela
    Quicksall, Zachary
    Zou, Fanggeng
    Chai, High Seng
    Younkin, Curtis
    Crook, Julia
    Pankratz, Vernon
    Carrasquillo, Minerva
    Krishnan, Siddharth
    Thuy Nguyen
    Ma, Li
    Malphrus, Kimberly
    Lincoln, Sarah
    Bisceglio, Gina
    Kolbert, Christopher
    Jen, Jin
    Petersen, Ronald
    Graff-Radford, Neill
    Dickson, Dennis
    Younkin, Steven
    Taner, Nilufer
    NEUROLOGY, 2013, 80
  • [32] Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
    Qian Zhang
    Julia Sidorenko
    Baptiste Couvy-Duchesne
    Riccardo E. Marioni
    Margaret J. Wright
    Alison M. Goate
    Edoardo Marcora
    Kuan-lin Huang
    Tenielle Porter
    Simon M. Laws
    Perminder S. Sachdev
    Karen A. Mather
    Nicola J. Armstrong
    Anbupalam Thalamuthu
    Henry Brodaty
    Loic Yengo
    Jian Yang
    Naomi R. Wray
    Allan F. McRae
    Peter M. Visscher
    Nature Communications, 11
  • [33] Late-onset autosomal dominant Alzheimer's disease
    Hancock, P.
    Larner, A. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 187 - 188
  • [34] Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture
    Zhang, Qian
    Sidorenko, Julia
    Couvy-Duchesne, Baptiste
    Marioni, Riccardo E.
    Wright, Margaret J.
    Goate, Alison M.
    Marcora, Edoardo
    Huang, Kuan-lin
    Porter, Tenielle
    Laws, Simon M.
    Sachdev, Perminder S.
    Mather, Karen A.
    Armstrong, Nicola J.
    Thalamuthu, Anbupalam
    Brodaty, Henry
    Yengo, Loic
    Yang, Jian
    Wray, Naomi R.
    McRae, Allan F.
    Visscher, Peter M.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [35] Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency
    Külkens, S
    Harting, I
    Sauer, S
    Zschocke, J
    Hoffmann, GF
    Gruber, S
    Bodamer, OA
    Kölker, S
    NEUROLOGY, 2005, 64 (12) : 2142 - 2144
  • [36] Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers
    Li, Qiaojun
    Lv, Xingping
    Jin, Fei
    Liao, Kun
    Gao, Liyuan
    Xu, Jiayuan
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [37] SORL1 variants and risk of late-onset Alzheimer's disease
    Li, Yonghong
    Rowland, Charles
    Catanese, Joseph
    Morris, John C.
    Lovestone, Simon
    O'Donovan, Michael C.
    Goate, Alison
    Owen, Michael
    Williams, Julie
    Grupe, Andrew
    NEUROBIOLOGY OF DISEASE, 2008, 29 (02) : 293 - 296
  • [38] In vivo validation of late-onset Alzheimer's disease genetic risk factors
    Sasner, Michael
    Preuss, Christoph
    Pandey, Ravi S.
    Uyar, Asli
    Garceau, Dylan
    Kotredes, Kevin P.
    Williams, Harriet
    Oblak, Adrian L.
    Lin, Peter Bor-Chian
    Perkins, Bridget
    Soni, Disha
    Ingraham, Cindy
    Lee-Gosselin, Audrey
    Lamb, Bruce T.
    Howell, Gareth R.
    Carter, Gregory W.
    ALZHEIMERS & DEMENTIA, 2024, 20 (07) : 4970 - 4984
  • [39] Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease
    Zhang, Qun
    Yu, Jin-Tai
    Zhu, Qi-Xiu
    Zhang, Wei
    Wu, Zhong-Chen
    Miao, Dan
    Tan, Lan
    BRAIN RESEARCH, 2010, 1348 : 216 - 221
  • [40] Etiology and Pathogenesis of Late-Onset Alzheimer's Disease
    Balin, Brian J.
    Hudson, Alan P.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2014, 14 (03)